These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Takayama T; Ohi M; Hayashi T; Miyanishi K; Nobuoka A; Nakajima T; Satoh T; Takimoto R; Kato J; Sakamaki S; Niitsu Y Gastroenterology; 2001 Sep; 121(3):599-611. PubMed ID: 11522744 [TBL] [Abstract][Full Text] [Related]
4. Somatic APC and K-ras codon 12 mutations in periampullary adenomas and carcinomas from familial adenomatous polyposis patients. Gallinger S; Vivona AA; Odze RD; Mitri A; O'Beirne CP; Berk TC; Bapat BV Oncogene; 1995 May; 10(9):1875-8. PubMed ID: 7753564 [TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene. Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045 [TBL] [Abstract][Full Text] [Related]
7. Increased frequency of the k-ras G12C mutation in MYH polyposis colorectal adenomas. Jones S; Lambert S; Williams GT; Best JM; Sampson JR; Cheadle JP Br J Cancer; 2004 Apr; 90(8):1591-3. PubMed ID: 15083190 [TBL] [Abstract][Full Text] [Related]
8. K-ras mutation and loss of heterozygosity of the adenomatous polyposis coli gene in patients with colorectal adenomas with in situ carcinoma. Zauber NP; Sabbath-Solitare M; Marotta SP; Bishop DT Cancer; 1999 Jul; 86(1):31-6. PubMed ID: 10391560 [TBL] [Abstract][Full Text] [Related]
9. DNA methylation patterns in adenomas from FAP, multiple adenoma and sporadic colorectal carcinoma patients. Wynter CV; Kambara T; Walsh MD; Leggett BA; Young J; Jass JR Int J Cancer; 2006 Feb; 118(4):907-15. PubMed ID: 16152625 [TBL] [Abstract][Full Text] [Related]
10. Intratumor heterogeneity of k-ras and p53 mutations among human colorectal adenomas containing early cancer. Giaretti W; Rapallo A; Sciutto A; Macciocu B; Geido E; Hermsen MA; Postma C; Baak JP; Williams RA; Meijer GA Anal Cell Pathol; 2000; 21(2):49-57. PubMed ID: 11310641 [TBL] [Abstract][Full Text] [Related]
12. K-ras2 activation and genome instability increase proliferation and size of FAP adenomas. Rapallo A; Sciutto A; Geido E; Orecchia R; Infusini E; Pujic N; d'Amore ES; Monaco R; Risio M; Rossini FP; Giaretti W Anal Cell Pathol; 1999; 19(1):39-46. PubMed ID: 10661623 [TBL] [Abstract][Full Text] [Related]
13. Somatic mutations of the APC, KRAS, and TP53 genes in nonpolypoid colorectal adenomas. van Wyk R; Slezak P; Hayes VM; Buys CH; Kotze MJ; de Jong G; Rubio C; Dolk A; Jaramillo E; Koizumi K; Grobbelaar JJ Genes Chromosomes Cancer; 2000 Feb; 27(2):202-8. PubMed ID: 10612810 [TBL] [Abstract][Full Text] [Related]
14. Lower incidence of K-ras codon 12 mutation in flat colorectal adenomas than in polypoid adenomas. Yamagata S; Muto T; Uchida Y; Masaki T; Sawada T; Tsuno N; Hirooka T Jpn J Cancer Res; 1994 Feb; 85(2):147-51. PubMed ID: 8144396 [TBL] [Abstract][Full Text] [Related]
15. Detection of genetic alterations in the p53 suppressor gene and the K-ras oncogene among different grades of dysplasia in patients with colorectal adenomas. Hosaka S; Aoki Y; Akamatsu T; Nakamura N; Hosaka N; Kiyosawa K Cancer; 2002 Jan; 94(1):219-27. PubMed ID: 11815980 [TBL] [Abstract][Full Text] [Related]